Anna Reischer
Impact in
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- Immune Cell Function and Interaction 4
- Immunotherapy and Immune Responses 3
- Phagocytosis and Immune Regulation 2
- Oncology 9
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 3
- Co-authors
- Alexandra Leutbecher (1 shared paper)Alexander Burges (1 shared paper)Fabian Trillsch (1 shared paper)Andreas Jung (1 shared paper)Michael von Bergwelt‐Baildon (4 shared papers)Marion S. Subklewe (1 shared paper)Sibylle Liebmann (1 shared paper)Bastian Czogalla (1 shared paper)
- Journals
- Theranostics (1 paper)Journal of Hematology & Oncology (1 paper)Oncology Reports (1 paper)European Journal of Cancer (1 paper)Nature Biomedical Engineering (1 paper)
- Partner nations
- GermanyFranceUnited States
In The Last Decade
Anna Reischer
13 papers receiving 389 citations
Peers
Comparison fields: 5 of 49
- Oncology 193
- Immunology 131
- Infectious Diseases 75
- Neurology 31
- Cancer Research 25
Countries citing papers authored by Anna Reischer
This map shows the geographic impact of Anna Reischer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Reischer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Reischer more than expected).
Fields of papers citing papers by Anna Reischer
This network shows the impact of papers produced by Anna Reischer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Reischer. The network helps show where Anna Reischer may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Reischer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 155 | |
| 2 | 2021 | 67 | |
| 3 | 2021 | 38 | |
| 4 | 2019 | 28 | |
| 5 | 2021 | 28 | |
| 6 | 2020 | 27 | |
| 7 | 2022 | 17 | |
| 8 | 2022 | 17 | |
| 9 | 2014 | 9 | |
| 10 | 2020 | 5 | |
| 11 | 2019 | 2 | |
| 12 | 2025 | 2 | |
| 13 | 2025 | 1 | |
| 14 | 2021 | 0 | |
| 15 | 2023 | 0 |
About Anna Reischer
Anna Reischer is a scholar working on Immunology, Oncology, Infectious Diseases, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 396 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Immune Cell Function and Interaction (4 papers), CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Lung Cancer Treatments and Mutations (2 papers), Phagocytosis and Immune Regulation (2 papers) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Oncology (193 citations), Immunology (131 citations), Infectious Diseases (75 citations), Neurology (31 citations) and Cancer Research (25 citations). Anna Reischer has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Alexandra Leutbecher, Alexander Burges, Fabian Trillsch, Andreas Jung, Michael von Bergwelt‐Baildon, Marion S. Subklewe, Sibylle Liebmann, Bastian Czogalla, Susanne Beyer and Thomas W. Kirchner. Their work appears in journals such as Theranostics, Journal of Hematology & Oncology, Oncology Reports, European Journal of Cancer and Nature Biomedical Engineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.